Production of inhalable submicrometer aerosols from conventional mesh nebulizers for improved respiratory drug delivery

Journal of Aerosol Science

Volumn 51, Issue , 2012, Pages 66-80

  Worth Longest, P ^a,b   Spence, Benjamin M ^a   Holbrook, Landon T ^a   Mossi, Karla M ^a   Son, Yoen Ju ^b   Hindle, Michael ^b  

^a Virginia Commonwealth University   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

CFD simulation of droplet evaporation; Droplet evaporation; Hygroscopic droplets; Nanoaerosols; Respiratory drug delivery; Two way coupled heat and mass transfer

Indexed keywords

ATMOSPHERIC MOVEMENTS; BIOCHEMISTRY; COMPUTATIONAL FLUID DYNAMICS; CONTROLLED DRUG DELIVERY; DROPS; EVAPORATION; HEAT TRANSFER; HUMIDITY CONTROL; MASS TRANSFER; MESH GENERATION; TARGETED DRUG DELIVERY;

COMPUTATIONAL FLUID DYNAMICS MODELING; COUPLED HEAT AND MASS TRANSFER; DROPLET EVAPORATION; NANOAEROSOLS; RESPIRATORY DRUG DELIVERIES; SUBMICROMETER PARTICLE; TEMPERATURE AND RELATIVE HUMIDITY; THERMODYNAMIC CONDITIONS;

AEROSOLS;

AERODYNAMICS; BIOAVAILABILITY; COMPUTATIONAL FLUID DYNAMICS; CONDENSATION; DISSOLUTION; DRUG; EVAPORATION; EXPERIMENTAL STUDY; FLOW PATTERN; HEAT TRANSFER; HYGROSCOPICITY; NUMERICAL MODEL; PARTICLE SIZE; RELATIVE HUMIDITY; RESPIRATION; THERMAL POWER;

AEROSOL; ARTICLE; COMPUTATIONAL FLUID DYNAMICS; DRUG DELIVERY SYSTEM; HUMIDITY; MEDICAL NEBULIZER; NANOMETER AEROSOL; PARTICLE SIZE; PRIORITY JOURNAL; SUBMICROMETER AEROSOL; TEMPERATURE;

EID: 84860642433     PISSN: 00218502     EISSN: 18791964     Source Type: Journal    
DOI: 10.1016/j.jaerosci.2012.04.002     Document Type: Article

References (58)

1. Abdelrahim M.E., Chrystyn H. Aerodynamic characteristics of nebulized terbutaline sulphate using the next generation impactor (NGI) and CEN method. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2009, 22(1):19-28.
2. Abdelrahim M.E., Plant P.K., Chrystyn H. The relative lung and systemic bioavailability of terbutaline following nebulisation in non-invasively ventilated patients. International Journal of Pharmaceutics 2011, 420(2):313-318.
3. Ari A., Harwood R., Sheard M., Dailey P., Fink J.B. In vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula. Pediatric Pulmonology 2011, 46(8):795-801.
4. Asgharian B., Price O.T. Deposition of ultrafine (nano) particles in the human lung. Inhalation Toxicology 2007, 19:1045-1054.
5. Azarmi S., Roa W.H., Lobenberg R. Targeted delivery of nanoparticles for the treatment of lung diseases. Advanced Drug Delivery Reviews 2008, 60:863-875.
6. Chan H.-K. Dry powder aerosol drug delivery-opportunities for colloid and surface scientists. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2006, 284-285:50-55.
7. Chan H.K., Kwok P.C.L. Production methods for nanodrug particles using the bottom-up approach. Advanced Drug Delivery Reviews 2011, 63(6):406-416.
8. Chen X., Young T.J., Sarkari M., Williams R.O., Johnston K.P. Preparation of cyclosporine A nanoparticls by evaporative precipitation into aqueous solution. International Journal of Pharmaceutics 2002, 242:3-14.
9. Cheng K.H., Cheng Y.S., Yeh H.C., Guilmette R.A., Simpson S.Q., Yang S.Q., Swift D.L. In vivo measurements of nasal airway dimensions and ultrafine aerosol depositing in human nasal and oral airways. Journal of Aerosol Science 1996, 27:785-801.
10. Couvreur P., Dubernet C., Puisieux F. Controlled drug-delivery with nanoparticles-current possibilities and future-trends. European Journal of Pharmaceutics and Biopharmaceutics 1995, 41(1):2-13.
11. Dandekar P., Venkataraman C., Mehra A. Pulmonary targeting of nanoparticle drug matrices. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2010, 23(6):343-353.
12. Dhand R. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respiratory Care 2002, 47(12):1406-1416.
13. Dhand R. Inhalation therapy in invasive and noninvasive mechanical ventilation. Current Opinion in Critical Care 2007, 13:27-38.
14. Dhand R. Aerosol delivery during mechanical ventilation: from basic techniques to new devices. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2008, 21(1):45-60.
15. El-Gendy N., Gorman E.M., Munson E.J., Berkland C. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. Journal of Pharmaceutical Sciences 2009, 98(8):2731-2746.
16. Fink J.B. Aerosol delivery to ventilated infant and pediatric patients. Respiratory Care 2004, 49(6):653-665.
17. Finlay W.H. The Mechanics of Inhaled Pharmaceutical Aerosols 2001, Academic Press, San Diego.
18. Fu H.J., Patel A.C., Holtzman M.J., Chen D.R. A new electrospray aerosol generator with high particle transmission efficiency. Aerosol Science and Technology 2011, 45(10):1176-1183.
19. Geller D.E., Pitlick W.H., Nardella P.A., Tracewell W.G., Ramsey B.W. Pharmacokinetics and bioavailability of aerosolized tobramycine in cyctic fibrosis. Chest 2002, 122:219-226.
20. Green D.W. Perry's Chemical Engineers' Handbook. 1997, McGraw-Hill, New York.
21. Guerrero M.L., Cuneo B.M., Hnatiuk O.W., Shorr A. Vapotherm: a novel high-flow oxygen delivery system. Chest 2003, 124(4). pp. 93S.
22. Hindle M., Gupta R., Cox K.A. Adding pharmaceutical flexibility to the capillary aerosol generator. Respiratory Drug Delivery IX 2004, 247-254. DHI Publishing, River Grove, IL. R.N. Dalby, P.R. Byron, J. Peart, J.D. Suman, S.J. Farr (Eds.).
23. Hindle M., Longest P.W. Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model. Pharmaceutical Research 2010, 27:1800-1811.
24. Hindle, M., & Longest, P.W. (2012). Condensational growth of combination drug-excipient submicrometer particles for targeted high efficiency pulmonary delivery: evaluation of formulation and delivery device. Journal of Pharmacy and Pharmacology, . http://dx.doi.org/10.1111/j.2042-7158.2012.01476.x.
25. Ijsebaert J.C., Geerse K.B., Marijnissen J.C.M., Lammers J.-W.J., Zanen P. Electro-hydrodynamic atomization of drug solutions for inhalation purposes. Journal of Applied Physiology 2001, 91:2735-2741.
26. Jaques P.A., Kim C.S. Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women. Inhalation Toxicology 2000, 12(8):715-731.
27. Kays W.M., Crawford M.E. Convective Heat and Mass Transfer 1993, McGraw-Hill, New York.
28. Kuhli M., Weiss M., Steckel H. A sampling and dilution system for droplet aerosols from medical nebulisers developed for use with an optical particle counter. Aerosol Science 2009, 40:523-533.
29. Lai S.K., Wang Y.-Y., Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Advanced Drug Delivery Reviews 2009, 61:158-171.
30. Longest P.W., Hindle M. Evaluation of the Respimat Soft Mist inhaler using a concurrent CFD and in vitro approach. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2009, 22(2):99-112.
31. Longest P.W., Hindle M. CFD simulations of enhanced condensational growth (ECG) applied to respiratory drug delivery with comparisons to in vitro data. Journal of Aerosol Science 2010, 41:805-820.
32. Longest P.W., Hindle M. Numerical model to characterize the size increase of combination drug and hygroscopic excipient nanoparticle aerosols. Aerosol Science and Technology 2011, 45:884-899.
33. Longest P.W., Hindle M. Condensational growth of combination drug-excipient submicrometer particles: comparison of CFD predictions with experimental results. Pharmaceutical Research 2012, 29:707-721.
34. Longest P.W., Hindle M., Das Choudhuri S., Byron P.R. Numerical simulations of capillary aerosol generation: CFD model development and comparisons with experimental data. Aerosol Science and Technology 2007, 41:952-973.
35. Longest P.W., McLeskey J.T., Hindle M. Characterization of nanoaerosol size change during enhanced condensational growth. Aerosol Science and Technology 2010, 44:473-483.
36. Longest P.W., Tian G., Hindle M. Improving the lung delivery of nasally administered aerosols during noninvasive ventilation-an application of enhanced condensational growth (ECG). Journal of Aerosol Medicine and Pulmonary Drug Delivery 2011, 24(2):103-118. 10.1089/jamp.2010.0849.
37. Longest P.W., Tian G., Walenga R.L., Hindle M. Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways. Pharmaceutical Research 2012, 10.1007/s11095-012-0691-y.
38. Longest P.W., Vinchurkar S. Validating CFD predictions of respiratory aerosol deposition: effects of upstream transition and turbulence. Journal of Biomechanics 2007, 40:305-316.
39. Longest P.W., Xi J. Effectiveness of direct Lagrangian tracking models for simulating nanoparticle deposition in the upper airways. Aerosol Science and Technology 2007, 41:380-397.
40. Longest P.W., Xi J. Condensational growth may contribute to the enhanced deposition of cigarette smoke particles in the upper respiratory tract. Aerosol Science and Technology 2008, 42:579-602.
41. Martonen T.B. Mathematical model for the selective deposition of inhaled pharmaceuticals. Journal of Pharmaceutical Sciences 1993, 82(12):1191-1199.
42. Newman S.P., Busse W.W. Evolution of dry powder inhaler design, formulation, and performance. Respiratory Medicine 2002, 96:293-304.
43. Nikander K., Prince I., Coughlin S., Warren S., Taylor G. Mode of breathing-tidal or slow and deep-through the I-neb adaptive delivery (ADD) system affects lung deposition of 99mTc-DTPA. Journal of Aerosol Medicine 2010, 23(S1):S37-S43.
44. Pitance L., Vecellio L., Leal T., Reychler G., Reychler H., Liistro G. Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2010, 23(6):389-396.
45. Rea H., McAuley S., Jayaram L., Garrett J., Hockey H., Storey L., O'Donnell G., Haru L., Payton M., O'Donnell K. The clinical utility of long-term humidification therapy in chronic airway disease. Respiratory Medicine 2010, 104:525-533.
46. Rubin B.K. Pediatric aerosol therapy: new devices and new drugs. Respiratory Care 2011, 56(9):1411-1421.
47. Skaria S., Smaldone G.C. Omron NE U22: comparison between vibrating mesh and jet nebulizer. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2010, 23(3):173-180.
48. Stein S.W., Myrdal P.B. A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions. Journal of Pharmaceutical Sciences 2004, 93:2158-2175.
49. Tian G., Longest P.W., Su G., Hindle M. Characterization of respiratory drug delivery with enhanced condensational growth (ECG) using an individual path model of the entire tracheobronchial airways. Annals of Biomedical Engineering 2011, 39(3):1136-1153.
50. Vinchurkar S., Longest P.W. Evaluation of hexahedral, prismatic and hybrid mesh styles for simulating respiratory aerosol dynamics. Computers and Fluids 2008, 37:317-331.
51. Wilcox D.C. Turbulence Modeling for CFD 1998, DCW Industries, Inc., California. 2nd ed.
52. Xi J., Longest P.W. Transport and deposition of micro-aerosols in realistic and simplified models of the oral airway. Annals of Biomedical Engineering 2007, 35(4):560-581.
53. Xi J., Longest P.W. Effects of oral airway geometry characteristics on the diffusional deposition of inhaled nanoparticles. ASME Journal of Biomechanical Engineering 2008, 130:011008.
54. Xi J., Longest P.W. Numerical predictions of submicrometer aerosol deposition in the nasal cavity using a novel drift flux approach. International Journal of Heat and Mass Transfer 2008, 51:5562-5577.
55. Yang J.Z., Young A.L., Chiang P.C., Thurston A., Pretzer D.K. Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies. Journal of Pharmaceutical Sciences 2008, 97:4869-4878.
56. Yurteri C.U., Hartman R.P.A., Marijnissen J.C.M. Producing pharmaceutical particles via electrospraying with an emphasis on nano and nano structured particles-a review. KONA Powder and Particle Journal 2010, 28:91-115.
57. Zhang G., David A., Wiedmann T.S. Performance of the vibrating membrane aerosol generation device: aeroneb micropump nebulizer. Journal of Aerosol Medicine 2007, 20(4):408-416.
58. Zhang Y., Gilbertson K., Finlay W.H. In vivo-in vitro comparison of deposition in three mouth-throat models with Qvar and Turbuhaler inhalers. Journal of Aerosol Medicine 2007, 20(3):227-235.